Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibition attenuates abdominal aortic aneurysm formation via enhanced macrophage-dependent efferocytosis (James S.T. Yao Resident Research Award Recipient supported by the SVS Foundation)

Speaker(s)

• 

  Michael J. Fassler, MD

  General Surgery Resident
  University of Florida
  Gainesville, Florida